View all cases
- Case details
- Status—ActionProcedural applicationCategoryFile-access requests (R. 262.1(b))
- Parties
- Claimants
- Sanofi Mature IPOperating co.
- Sanofi Winthrop IndustrieOperating co.
- Sanofi-Aventis FranceOperating co.
- Sanofi-Aventis GmbHOperating co.
- Sanofi BelgiumOperating co.
- Sanofi-Aventis Deutschland GmbHOperating co.
- Sanofi S.r.l.Operating co.
- Sanofi B.V.Operating co.
- Sanofi - Produtos Farmaceuticos LdaOperating co.
- Sanofi ABOperating co.
- Sanofi A/SOperating co.
Representatives- Frédéric Chevallier-Herbert Smith Freehills Kramer LLP
Respondents- STADAPHARM GmbHOperating co.
- STADA Arzneimittel AGOperating co.
- STADA Nordic ApSOperating co.
- Medac Gesellschaft für klinische Spezialpräparate m.b.H.Operating co.
Representatives- Daniel Hoppe-Preu Bohlig & Partner
- Alexander Eisenführ-Uexkull + Stolberg
- Division
- Munich LD
- Technology
- ChemistryPharmaceuticals
- Language
- —
- First decided
- Mar 19, 2025
- EPO Opposition
- Glenmark Pharmaceuticals Europe Ltd2021-03-10
- Accord Healthcare LtdAdmissible2021-03-10
- Teva Pharmaceutical Industries Ltd.Admissible2021-03-10
- EVER Valinject GmbHWithdrawn2021-03-12
- Zentiva k.s.Admissible2021-03-12
- medac Gesellschaft für klinische Spezialpräparate mbHWithdrawn2021-03-22
- Fresenius Kabi Deutschland GmbHAdmissible2021-03-23
- Dr. Reddy's Laboratories Ltd.Admissible2021-03-31
- Betapharm Arzneimittel GmbHAdmissible2021-03-31
- Generics (U.K.) LimitedAdmissible2021-06-08
- Vossius & Partner Patentanwälte Rechtsanwälte mbBAdmissible2021-12-03
- STADA Arzneimittel AGAdmissible2021-12-09
- Maiwald GmbHAdmissible2021-12-10
- Accord Healthcare S.L.U.2024-08-30
How this compares
How long the court takes to reach a first decision.
| Median days to first decision | |
|---|---|
| All UPC | 124 |
| Munich LD | Locked |
| Judge Matthias Zigann | Locked |
| Judge Alima Zana | Locked |
| Judge Tobias Pichlmaier | Locked |
| Judge Carola Wagner | Locked |
At the UPC: Sanofi Group (33 cases)·STADAPHARM GmbH (10 cases)
Start 14-day free trialAlready a user? Sign in
Related cases
All proceedings on this patentThis dispute contains 11 other proceedings
UPC CoA 22/2026·UPC CoA 25/2026·UPC CFI 106/2026·UPC CFI 108/2026·UPC CFI 496/2024 and 6 more
10 other defendants litigating the same or a related patent
UPC CoA 23/2026·UPC CoA 24/2026·UPC CoA 26/2026·UPC CoA 27/2026·UPC CFI 503/2024 and 5 more
Decisions
- 2025-03-19Application RoP 265Public
Summary: Procedural order by Munich Local Division (UPC_CFI_146/2024, 26 March 2025) granting Medac's application to withdraw its third-party access application, ordering deletion of a confidential Sanofi letter that Medac had uploaded without authorisation, imposing the deletion costs on Medac, and issuing a formal warning to Medac's representative for negligent conduct in uploading a privileged document. The court declined to award costs in the R.262(1)(b) application.
Show the legal issues (4)
- Withdrawal of application (R. 265 RoP)
- Professional conduct / privilege breach (R. 290.2 RoP, Code of Conduct)
- Deletion of uploaded document (CMS)
- Costs in R.262(1)(b) proceedings
Documents
- 8BAB8521B6B4674E3BB1E57679069DD4_en.pdf2025-03-19EN